KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Leases (2019 - 2024)

Historic Leases for Abbott Laboratories (ABT) over the last 5 years, with Q4 2024 value amounting to $1.1 billion.

  • Abbott Laboratories' Leases fell 418.89% to $1.1 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 billion, marking a year-over-year decrease of 418.89%. This contributed to the annual value of $1.1 billion for FY2024, which is 418.89% down from last year.
  • According to the latest figures from Q4 2024, Abbott Laboratories' Leases is $1.1 billion, which was down 418.89% from $1.1 billion recorded in Q4 2023.
  • In the past 5 years, Abbott Laboratories' Leases ranged from a high of $1.2 billion in Q4 2021 and a low of $1.1 billion during Q4 2024
  • Moreover, its 4-year median value for Leases was $1.1 billion (2020), whereas its average is $1.1 billion.
  • Per our database at Business Quant, Abbott Laboratories' Leases skyrocketed by 1788.01% in 2020 and then tumbled by 418.89% in 2024.
  • Over the past 4 years, Abbott Laboratories' Leases (Quarter) stood at $1.1 billion in 2020, then grew by 4.72% to $1.2 billion in 2021, then decreased by 2.69% to $1.1 billion in 2023, then decreased by 4.19% to $1.1 billion in 2024.
  • Its last three reported values are $1.1 billion in Q4 2024, $1.1 billion for Q4 2023, and $1.2 billion during Q4 2021.